1-3 of 3
Susan Arentsen-Peters
Close
Sort by
Journal Articles

Selective Inhibition of Class II HDAC Isoforms 4 and 5 Provides a Promising Therapeutic Intervention for MLL -Rearranged Acute Lymphoblastic Leukemia in Infants

Tamara C.A.I. Verbeek, Susan Arentsen-Peters, Patricia Garrido Castro, Sandra Pinhancos, Kirsten Vrenken, Aida Varela-Moreira, M. Emmy Dolman, Bianca Koopmans, Rob Pieters, Ronald W. Stam
Journal: Blood
Blood (2021) 138 (Supplement 1): 2206.
https://doi.org/10.1182/blood-2021-147164
Published: 2021
Journal Articles

Nucleophosmin Gene Mutations Identify a Favorable Risk Group in Childhood Acute Myeloid Leukemia with a Normal Karyotype.

Iris H. Hollink, Christian M. Zwaan, Marry M. van den Heuvel-Eibrink, Martin Zimmerman, Susan Arentsen-Peters, Rob Pieters, Jacqueline Cloos, Gertjan J. Kaspers, Siebold S. De Graaf, Ursula Creutzig, Dirk Reinhardt, Christian Thiede
Journal: Blood
Blood (2007) 110 (11): 366.
https://doi.org/10.1182/blood.V110.11.366.366
Published: 2007
Journal Articles

A Novel Approach for Analyzing Gene Expression Profiles Defines Two Distinct Subgroups of t(4;11) Positive Infant Acute Lymphoblastic Leukemia Patients.

Ronald W. Stam, Stefan Bohlander, Renate Kirschner-Schwabe, Susan Arentsen-Peters, Rob Pieters, Theo Dingermann, Rolf Marschalek
Journal: Blood
Blood (2007) 110 (11): 4282.
https://doi.org/10.1182/blood.V110.11.4282.4282
Published: 2007